ieCrowd offers investors a new way to invest in breakthrough health innovations while mitigating some of the risks typically associated with early-stage investing. At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Currently, ieCrowd is working on two innovations - Kite and Nuuma:
Investing in ieCrowd provides:
$14,000,000 raised from investors worldwide including angel investors, funds, and family offices.July, 2016
$20,000,000 Letter of Interest received for Nuuma, ieCrowd's nano-materials-based gas-sensor chip.June, 2016
Kite signed a six-year agreement with potential value of $80,000,000 for exclusive distribution of Kite products in Japan and South Korea.March, 2014
Nuuma received $2,800,000 in grant funding from the National Institute of Health, Center for Nanoscience Innovation for Defense and others.February, 2010
Completed manufacturing and launched InDemand campaign with Indiegogo to sell Kite Shield, an effective, DEET-free mosquito repellent.July, 2016
$557,000 raised from 11,254 backers via Indiegogo campaign for Kite Patch, a future follow-on product for Kite Shield.June, 2013